Press Resease

Clinical Trial Imaging Market - Global Industry Analysis

Clinical Trial Imaging Market by Services (Project and Data Management, Clinical Trial Design and Consultation, Reading and Analytical, Operational Imaging and Others), By Modality (CT, MRI, PET, Ultrasound, X-Ray and Others), By End Use (Biotechnology and Pharmaceutical companies, Medical Devices Manufacturers, Contract Research Organizations (CROs), Academic and Government Research Institutes and Others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 – 2028

Published Date: 12-Jul-2021 Category: Medical Device Report Format : PDF Pages: 140 Report Code: ZMR-1098 Status : Published

The global clinical trial imaging system market accounted for USD 963.36 Billion in 2020 and is expected to reach USD 1450.92 Billion by 2028, growing at a CAGR of 6.54% from 2021 to 2028.

Description

Market Overview

The global clinical trial imaging system market accounted for USD 963.36 Billion in 2020 and is expected to reach USD 1450.92 Billion by 2028, growing at a CAGR of 6.54% from 2021 to 2028.

Imaging has traditionally played 3 roles that relate to clinical trials: detection, characterization, and monitoring/assessment. Over the last two decades, the use of imaging in clinical trials has risen exponentially. In many trials, imaging data is increasingly being used to support the primary endpoint. An increase in the number of contract research organizations, in the geriatric population with chronic diseases, and a rise in R&D expenditure are some of the factors that would drive growth of the clinical trial imaging market. Furthermore, the emerging of pharmaceutical and biotechnology sectors, as well as of small and portable equipments market is likely to give opportunities for the clinical trial imaging market to grow. The improvements and advancements in medical imaging technology and their increasing use throughout the world are fuelling the demand for imaging technologies in clinical trials.

COVID-19 Impact Analysis

During the COVID-19 pandemic, the unprecedented demand for hospital services severely hampered the ability to respond to non-acute health requirements. Non-COVID-19-related research activity has had to be curtailed in order to relieve the load on health-care systems, especially imaging and laboratory services. To lower the danger of infection, measures to reduce hospital visits have been implemented.

Imaging, on the other hand, necessitates hospital visits and intimate contact with workers and equipment, both of which might spread disease. Unless cleaned, equipment used to image COVID-19 patients may retain virus on its surface for days. Imaging processing is significantly slowed and throughput is reduced due to the necessity for social distancing and disinfection equipment.

Growth Factors

Pharmaceutical companies have grown in popularity across the world as science and technology have advanced. As the number of pharmaceutical and biotechnology companies grow, it has become increasingly important for manufacturers to provide the finest possible treatment or therapy to end users, as the companies face more competition.

The rise in demand for clinical trial imaging is primarily due to the growing geriatric population and the rising prevalence of chronic diseases. Another factor driving the growth of the clinical trial imaging market is increasing research and development capabilities for drug discovery against a variety of ailments.

Report Scope:

Report Attribute Details
Base Year 2020
Historic Years 2016 - 2020
Forecast Years 2021 - 2028
Segments Covered By Product Type, By Application, and By End Use
Forecast Units Value (USD Billion), and Volume (Units)
Quantitative Units Revenue in USD million/billion and CAGR from 2021 to 2028
Regions Covered North America, Europe, Asia Pacific, Latin America, and Middle East & Africa, and Rest of World
Countries Covered U.S., Canada, Mexico, U.K., Germany, France, Italy, Spain, China, India, Japan, South Korea, Brazil, Argentina, GCC Countries, and South Africa, among others
Number of Companies Covered 10 companies with scope for including additional 15 companies upon request
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, market attractiveness analysis by segments and region, company market share analysis, and COVID-19 impact analysis.
Customization Scope Avail customized purchase options to meet your exact research needs.

Services Segment Analysis Preview

Project and Data Management segment held a share of around 30% in 2020. This is attributable to the fact that imaging-based clinical trials often need data management and workflow integration involving several stakeholders. Operational expertise and trial workflow development, project tracking, converting scans into digital images, regulatory control & quality assurance, real-time trial status report, setup and management of MRI centers, data management, and reporting and issue resolution are some of the services offered. Few governments across the globe have authorized the use of cloud-based servers that protect all medical imaging information, including annotated and basic pictures, protects reports from natural disasters, and allows for faster and easier retrieval.

End Use Industry Segment Analysis Preview

Biotechnology and Pharmaceutical Comapnies segment will grow at a CAGR of over 5% from 2021 to 2028. This is attributable to the necessity to find innovative treatments and therapies to cure chronic diseases. As the number of biotechnology and pharmaceutical businesses grows, manufacturers must provide the greatest available medicine/drug to end-users to stay competitive. As biotechnology and pharmaceutical firms make more innovative drug discoveries, the need for clinical trial imaging will rise, further boosting the market.

Regional Analysis Preview

North America region held a share of 30% in 2020. This is attributable to the rising prevalence of chronic diseases and the growing geriatric population, the regional market is expected to rise. Aside from that, advancements in healthcare infrastructure have made it possible to diagnose and treat chronic diseases more efficiently. The US Food and Drug Administration (FDA) and other regulatory agencies have also played a key role in achieving trial registration objectives to date. Considering all of these factors, the regional market is expected to maintain its market position over the forecast period.

The Asia Pacific region is projected to grow at a CAGR of around 5% over the forecast period. This can be attributed to the region's rapid population expansion and increased research and development activities. In addition, traditional and advanced devices and therapies are in great demand across the Asia Pacific region.

Key Market Players & Competitive Landscape

Some of key players in clinical trial imaging market are Bioclinica Inc, Ixico PLC, Icon PLC, Intrinsic Imaging LLC, Radiant Sage LLC, Parexel International Corporation, Biomedical Systems Worldcare Clinical, Medpace, Navitas Life Sciences, Prism Clinical Imaging, Resonance Health, VirtualScopic Inc and BioTelemetric, Inc among others.

Several technological patents have been filed to improve image assessment and capturing. Furthermore, imaging core lab players supply unique technologies that are likely to assist pharmaceutical companies in shortening development timelines. For example, IXICO's Assessa reading tool assists in better decision making in clinical trials for memory-related diseases including schizophrenia, Parkinson's, and Alzheimer's disease, as well as neurological illnesses including dementia and cognitive impairment. 

The global clinical trial imaging market is segmented as follows:

By Services

  • Project and Data Management
  • Clinical Trial Design and Consultation
  • Reading and Analytical
  • Operational Imaging
  • Others

By Modality

  • CT
  • MRI
  • PET
  • Ultrasound
  • X-Ray
  • Others

By End Use

  • Biotechnology and Pharmaceutical Companies
  • Medical Devices Manufacturers
  • Contract Research Organizations (CROs)
  • Academic and Government Research Institutes
  • Others

By Region

  • North America
    • The U.S.
    • Canada
  • Europe
    • France
    • The UK
    • Spain
    • Germany
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Services
        • 2.1.1.2. Market Attractiveness Analysis, By Modality
        • 2.1.1.3. Market Attractiveness Analysis, By End Use
        • 2.1.1.4. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Clinical Trial Imaging Market, 2016 – 2028 (USD Billion)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Clinical Trial Imaging Market – Services Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Services, 2020 & 2028
    • 4.2. Project and Data Management
      • 4.2.1. Market Size and Forecast, By Region (USD Billion)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Clinical Trial Design and Consultation
      • 4.3.1. Market Size and Forecast, By Region (USD Billion)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.4. Reading and Analytical
      • 4.4.1. Market Size and Forecast, By Region (USD Billion)
      • 4.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.5. Operational Imaging
      • 4.5.1. Market Size and Forecast, By Region (USD Billion)
      • 4.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.6. Others
      • 4.6.1. Market Size and Forecast, By Region (USD Billion)
      • 4.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Clinical Trial Imaging Market – Modality Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Modality, 2020 & 2028
    • 5.2. CT
      • 5.2.1. Market Size and Forecast, By Region (USD Billion)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. MRI
      • 5.3.1. Market Size and Forecast, By Region (USD Billion)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. PET
      • 5.4.1. Market Size and Forecast, By Region (USD Billion)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Ultrasound
      • 5.5.1. Market Size and Forecast, By Region (USD Billion)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. X-Ray
      • 5.6.1. Market Size and Forecast, By Region (USD Billion)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Others
      • 5.7.1. Market Size and Forecast, By Region (USD Billion)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 6 Clinical Trial Imaging Market – End Use Segment Analysis
    • 6.1. Overview
      • 6.1.1. Market Revenue Share, By End Use, 2020 & 2028
    • 6.2. Biotechnulogy and Pharmaceutical Companies
      • 6.2.1. Market Size and Forecast, By Region (USD Billion)
      • 6.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.3. Medical Devices Manufacturers
      • 6.3.1. Market Size and Forecast, By Region (USD Billion)
      • 6.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.4. Contract Research Organizations (CROs)
      • 6.4.1. Market Size and Forecast, By Region (USD Billion)
      • 6.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.5. Academic and Government Research Institutes
      • 6.5.1. Market Size and Forecast, By Region (USD Billion)
      • 6.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.6. Others
      • 6.6.1. Market Size and Forecast, By Region (USD Billion)
      • 6.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 6.6.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 7 Clinical Trial Imaging Market – Regional Analysis
    • 7.1. Overview
      • 7.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 7.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Billion)
    • 7.2. North America
      • 7.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.2.2. North America Market Revenue, By Services, 2016 – 2028
      • 7.2.3. North America Market Revenue, By Modality, 2016 – 2028
      • 7.2.4. North America Market Revenue, By End Use, 2016 – 2028
      • 7.2.5. U.S.
        • 7.2.5.1. U.S. Market Revenue, By Services, 2016 – 2028
        • 7.2.5.2. U.S. Market Revenue, By Modality, 2016 – 2028
        • 7.2.5.3. U.S. Market Revenue, By End Use, 2016 – 2028
      • 7.2.6. Canada
        • 7.2.6.1. Canada Market Revenue, By Services, 2016 – 2028
        • 7.2.6.2. Canada Market Revenue, By Modality, 2016 – 2028
        • 7.2.6.3. Canada Market Revenue, By End Use, 2016 – 2028
      • 7.2.7. Mexico
        • 7.2.7.1. Mexico Market Revenue, By Services, 2016 – 2028
        • 7.2.7.2. Mexico Market Revenue, By Modality, 2016 – 2028
        • 7.2.7.3. Mexico Market Revenue, By End Use, 2016 – 2028
    • 7.3. Europe
      • 7.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.3.2. Europe Market Revenue, By Services, 2016 – 2028
      • 7.3.3. Europe Market Revenue, By Modality, 2016 – 2028
      • 7.3.4. Europe Market Revenue, By End Use, 2016 – 2028
      • 7.3.5. Germany
        • 7.3.5.1. Germany Market Revenue, By Services, 2016 – 2028
        • 7.3.5.2. Germany Market Revenue, By Modality, 2016 – 2028
        • 7.3.5.3. Germany Market Revenue, By End Use, 2016 – 2028
      • 7.3.6. France
        • 7.3.6.1. France Market Revenue, By Services, 2016 – 2028
        • 7.3.6.2. France Market Revenue, By Modality, 2016 – 2028
        • 7.3.6.3. France Market Revenue, By End Use, 2016 – 2028
      • 7.3.7. U.K.
        • 7.3.7.1. U.K. Market Revenue, By Services, 2016 – 2028
        • 7.3.7.2. U.K. Market Revenue, By Modality, 2016 – 2028
        • 7.3.7.3. U.K. Market Revenue, By End Use, 2016 – 2028
      • 7.3.8. Italy
        • 7.3.8.1. Italy Market Revenue, By Services, 2016 – 2028
        • 7.3.8.2. Italy Market Revenue, By Modality, 2016 – 2028
        • 7.3.8.3. Italy Market Revenue, By End Use, 2016 – 2028
      • 7.3.9. Spain
        • 7.3.9.1. Spain Market Revenue, By Services, 2016 – 2028
        • 7.3.9.2. Spain Market Revenue, By Modality, 2016 – 2028
        • 7.3.9.3. Spain Market Revenue, By End Use, 2016 – 2028
      • 7.3.10. Rest of Europe
        • 7.3.10.1. Rest of Europe Market Revenue, By Services, 2016 – 2028
        • 7.3.10.2. Rest of Europe Market Revenue, By Modality, 2016 – 2028
        • 7.3.10.3. Rest of Europe Market Revenue, By End Use, 2016 – 2028
    • 7.4. Asia Pacific
      • 7.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.4.2. Asia Pacific Market Revenue, By Services, 2016 – 2028
      • 7.4.3. Asia Pacific Market Revenue, By Modality, 2016 – 2028
      • 7.4.4. Asia Pacific Market Revenue, By End Use, 2016 – 2028
      • 7.4.5. China
        • 7.4.5.1. China Market Revenue, By Services, 2016 – 2028
        • 7.4.5.2. China Market Revenue, By Modality, 2016 – 2028
        • 7.4.5.3. China Market Revenue, By End Use, 2016 – 2028
      • 7.4.6. Japan
        • 7.4.6.1. Japan Market Revenue, By Services, 2016 – 2028
        • 7.4.6.2. Japan Market Revenue, By Modality, 2016 – 2028
        • 7.4.6.3. Japan Market Revenue, By End Use, 2016 – 2028
      • 7.4.7. India
        • 7.4.7.1. India Market Revenue, By Services, 2016 – 2028
        • 7.4.7.2. India Market Revenue, By Modality, 2016 – 2028
        • 7.4.7.3. India Market Revenue, By End Use, 2016 – 2028
      • 7.4.8. South Korea
        • 7.4.8.1. South Korea Market Revenue, By Services, 2016 – 2028
        • 7.4.8.2. South Korea Market Revenue, By Modality, 2016 – 2028
        • 7.4.8.3. South Korea Market Revenue, By End Use, 2016 – 2028
      • 7.4.9. South-East Asia
        • 7.4.9.1. South-East Asia Market Revenue, By Services, 2016 – 2028
        • 7.4.9.2. South-East Asia Market Revenue, By Modality, 2016 – 2028
        • 7.4.9.3. South-East Asia Market Revenue, By End Use, 2016 – 2028
      • 7.4.10. Rest of Asia Pacific
        • 7.4.10.1. Rest of Asia Pacific Market Revenue, By Services, 2016 – 2028
        • 7.4.10.2. Rest of Asia Pacific Market Revenue, By Modality, 2016 – 2028
        • 7.4.10.3. Rest of Asia Pacific Market Revenue, By End Use, 2016 – 2028
    • 7.5. Latin America
      • 7.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.5.2. Latin America Market Revenue, By Services, 2016 – 2028
      • 7.5.3. Latin America Market Revenue, By Modality, 2016 – 2028
      • 7.5.4. Latin America Market Revenue, By End Use, 2016 – 2028
      • 7.5.5. Brazil
        • 7.5.5.1. Brazil Market Revenue, By Services, 2016 – 2028
        • 7.5.5.2. Brazil Market Revenue, By Modality, 2016 – 2028
        • 7.5.5.3. Brazil Market Revenue, By End Use, 2016 – 2028
      • 7.5.6. Argentina
        • 7.5.6.1. Argentina Market Revenue, By Services, 2016 – 2028
        • 7.5.6.2. Argentina Market Revenue, By Modality, 2016 – 2028
        • 7.5.6.3. Argentina Market Revenue, By End Use, 2016 – 2028
      • 7.5.7. Rest of Latin America
        • 7.5.7.1. Rest of Latin America Market Revenue, By Services, 2016 – 2028
        • 7.5.7.2. Rest of Latin America Market Revenue, By Modality, 2016 – 2028
        • 7.5.7.3. Rest of Latin America Market Revenue, By End Use, 2016 – 2028
    • 7.6. The Middle-East and Africa
      • 7.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Billion)
      • 7.6.2. The Middle-East and Africa Market Revenue, By Services, 2016 – 2028
      • 7.6.3. The Middle-East and Africa Market Revenue, By Modality, 2016 – 2028
      • 7.6.4. The Middle-East and Africa Market Revenue, By End Use, 2016 – 2028
      • 7.6.5. GCC Countries
        • 7.6.5.1. GCC Countries Market Revenue, By Services, 2016 – 2028
        • 7.6.5.2. GCC Countries Market Revenue, By Modality, 2016 – 2028
        • 7.6.5.3. GCC Countries Market Revenue, By End Use, 2016 – 2028
      • 7.6.6. South Africa
        • 7.6.6.1. South Africa Market Revenue, By Services, 2016 – 2028
        • 7.6.6.2. South Africa Market Revenue, By Modality, 2016 – 2028
        • 7.6.6.3. South Africa Market Revenue, By End Use, 2016 – 2028
      • 7.6.7. Rest of Middle-East Africa
        • 7.6.7.1. Rest of Middle-East Africa Market Revenue, By Services, 2016 – 2028
        • 7.6.7.2. Rest of Middle-East Africa Market Revenue, By Modality, 2016 – 2028
        • 7.6.7.3. Rest of Middle-East Africa Market Revenue, By End Use, 2016 – 2028
  • Chapter No. 8 Clinical Trial Imaging Market – Industry Analysis
    • 8.1. Introduction
    • 8.2. Market Drivers
      • 8.2.1. Driving Factor 1 Analysis
      • 8.2.2. Driving Factor 2 Analysis
    • 8.3. Market Restraints
      • 8.3.1. Restraining Factor Analysis
    • 8.4. Market Opportunities
      • 8.4.1. Market Opportunity Analysis
    • 8.5. Porter’s Five Forces Analysis
    • 8.6. PEST Analysis
    • 8.7. Regulatory Landscape
    • 8.8. Technology Landscape
    • 8.9. Regional Market Trends
      • 8.9.1. North America
      • 8.9.2. Europe
      • 8.9.3. Asia Pacific
      • 8.9.4. Latin America
      • 8.9.5. The Middle-East and Africa
    • 8.10. Pricing Analysis
    • 8.11. Value Chain Analysis
    • 8.12. Downstream Buyers
    • 8.13. Distributors/Traders List
  • Chapter No. 9 Competitive Landscape
    • 9.1. Company Market Share Analysis – 2019
      • 9.1.1. Global Clinical Trial Imaging Market: Company Market Share, 2019
      • 9.1.2. Global Clinical Trial Imaging Market, Company Market Revenue, 2016 – 2019 (USD Billion)
      • 9.1.3. Global Clinical Trial Imaging Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 9.1.4. Global Clinical Trial Imaging Market: Radar Determinant Chart, 2019
    • 9.2. Strategic Developments
      • 9.2.1. Acquisitions & Mergers
      • 9.2.2. New Product Launch
      • 9.2.3. Regional Expansion
    • 9.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 10 Company Profiles
    • 10.1. Bioclinica Inc.
      • 10.1.1. Company Overview
      • 10.1.2. Key Executives
      • 10.1.3. Product Portfolio
      • 10.1.4. Financial Overview
      • 10.1.5. Operating Business Segments
      • 10.1.6. Business Performance
      • 10.1.7. Recent Developments
    • 10.2. Ixico PLC
    • 10.3. Icon PLC
    • 10.4. Intrinsic Imaging LLC
    • 10.5. Radiant Sage LLC
    • 10.6. Parexel International Corporation
    • 10.7. Biomedical Systems Worldcare Clinical
    • 10.8. Medpace
    • 10.9. Navitas Life Sciences
    • 10.10. Prism Clinical Imaging
    • 10.11. Resonance Health
    • 10.12. VirtualScopic Inc.
    • 10.13. BioTelemetric, Inc.
  • Chapter No. 11 Marketing Strategy Analysis
    • 11.1. Marketing Channel
    • 11.2. Direct Marketing
    • 11.3. Indirect Marketing
    • 11.4. Marketing Channel Development Trends
    • 11.5. Economic/Pulitical Environmental Change
  • Chapter No. 12 Research Methodology
    • 12.1. Research Methodology
    • 12.2. Phase I - Secondary Research
    • 12.3. Phase II - Data Modeling
      • 12.3.1. Company Share Analysis Model
      • 12.3.2. Revenue Based Modeling
    • 12.4. Phase III - Primary Research
    • 12.5. Research Limitations
      • 12.5.1. Assumptions

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Services
FIG NO. 2. Market Attractiveness Analysis, By Modality
FIG NO. 3. Market Attractiveness Analysis, By End Use
FIG NO. 4. Market Attractiveness Analysis, By Region
FIG NO. 5. Global Clinical Trial Imaging Market Revenue, 2016 – 2028 (USD Billion)
FIG NO. 6. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 7. Market Revenue Share, By Services, 2020 & 2028
FIG NO. 8. Global Clinical Trial Imaging Market for Project and Data Management, Revenue (USD Billion) 2016 – 2028
FIG NO. 9. Comparative Revenue Analysis of Clinical Trial Imaging Market for Project and Data Management, By Country, 2020 & 2028
FIG NO. 10. Global Clinical Trial Imaging Market for Clinical Trial Design and Consultation, Revenue (USD Billion) 2016 – 2028
FIG NO. 11. Comparative Revenue Analysis of Clinical Trial Imaging Market for Clinical Trial Design and Consultation, By Country, 2020 & 2028
FIG NO. 12. Global Clinical Trial Imaging Market for Reading and Analytical, Revenue (USD Billion) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Clinical Trial Imaging Market for Reading and Analytical, By Country, 2020 & 2028
FIG NO. 14. Global Clinical Trial Imaging Market for Operational Imaging, Revenue (USD Billion) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Clinical Trial Imaging Market for Operational Imaging, By Country, 2020 & 2028
FIG NO. 16. Global Clinical Trial Imaging Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 17. Comparative Revenue Analysis of Clinical Trial Imaging Market for Others, By Country, 2020 & 2028
FIG NO. 18. Market Revenue Share, By Modality, 2020 & 2028
FIG NO. 19. Global Clinical Trial Imaging Market for CT, Revenue (USD Billion) 2016 – 2028
FIG NO. 20. Comparative Revenue Analysis of Clinical Trial Imaging Market for CT, By Country, 2020 & 2028
FIG NO. 21. Global Clinical Trial Imaging Market for MRI, Revenue (USD Billion) 2016 – 2028
FIG NO. 22. Comparative Revenue Analysis of Clinical Trial Imaging Market for MRI, By Country, 2020 & 2028
FIG NO. 23. Global Clinical Trial Imaging Market for PET, Revenue (USD Billion) 2016 – 2028
FIG NO. 24. Comparative Revenue Analysis of Clinical Trial Imaging Market for PET, By Country, 2020 & 2028
FIG NO. 25. Global Clinical Trial Imaging Market for Ultrasound, Revenue (USD Billion) 2016 – 2028
FIG NO. 26. Comparative Revenue Analysis of Clinical Trial Imaging Market for Ultrasound, By Country, 2020 & 2028
FIG NO. 27. Global Clinical Trial Imaging Market for X-Ray, Revenue (USD Billion) 2016 – 2028
FIG NO. 28. Comparative Revenue Analysis of Clinical Trial Imaging Market for X-Ray, By Country, 2020 & 2028
FIG NO. 29. Global Clinical Trial Imaging Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 30. Comparative Revenue Analysis of Clinical Trial Imaging Market for Others, By Country, 2020 & 2028
FIG NO. 31. Market Revenue Share, By End Use, 2020 & 2028
FIG NO. 32. Global Clinical Trial Imaging Market for Biotechnology and Pharmaceutical Companies, Revenue (USD Billion) 2016 – 2028
FIG NO. 33. Comparative Revenue Analysis of Clinical Trial Imaging Market for Biotechnology and Pharmaceutical Companies, By Country, 2020 & 2028
FIG NO. 34. Global Clinical Trial Imaging Market for Medical Devices Manufacturers, Revenue (USD Billion) 2016 – 2028
FIG NO. 35. Comparative Revenue Analysis of Clinical Trial Imaging Market for Medical Devices Manufacturers, By Country, 2020 & 2028
FIG NO. 36. Global Clinical Trial Imaging Market for Contract Research Organizations (CROs), Revenue (USD Billion) 2016 – 2028
FIG NO. 37. Comparative Revenue Analysis of Clinical Trial Imaging Market for Contract Research Organizations (CROs), By Country, 2020 & 2028
FIG NO. 38. Global Clinical Trial Imaging Market for Academic and Government Research Institutes, Revenue (USD Billion) 2016 – 2028
FIG NO. 39. Comparative Revenue Analysis of Clinical Trial Imaging Market for Academic and Government Research Institutes, By Country, 2020 & 2028
FIG NO. 40. Global Clinical Trial Imaging Market for Others, Revenue (USD Billion) 2016 – 2028
FIG NO. 41. Comparative Revenue Analysis of Clinical Trial Imaging Market for Others, By Country, 2020 & 2028
FIG NO. 42. Global Clinical Trial Imaging Market Revenue Share, By Region, 2020 & 2028
FIG NO. 43. North America Clinical Trial Imaging Market Revenue, 2016 - 2028 (USD Billion)
FIG NO. 44. Porter’s Five Forces Analysis for Global Clinical Trial Imaging Market
FIG NO. 45. PEST Analysis for Global Clinical Trial Imaging Market
FIG NO. 46. Pricing Analysis for Global Clinical Trial Imaging Market
FIG NO. 47. Value Chain Analysis for Global Clinical Trial Imaging Market
FIG NO. 48. Company Share Analysis, 2019
FIG NO. 49. Radar Determinant Chart, 2019
FIG NO. 50. Company Strategic Developments – Heat Map Analysis
FIG NO. 51. Bioclinica Inc. Business Segment Revenue Share, 2020 (%)
FIG NO. 52. Bioclinica Inc. Geographical Segment Revenue Share, 2020 (%)
FIG NO. 53. Market Channels
FIG NO. 54. Marketing Channel Development Trend
FIG NO. 55. Growth in World Gross Product, 2008-2018
FIG NO. 56. Research Methodology – Detailed View
FIG NO. 57. Research Methodology


List of Tables 

TABLE NO. 1. Global Clinical Trial Imaging Market: Snapshot
TABLE NO. 2. Quarterly Clinical Trial Imaging Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Clinical Trial Imaging Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Billion)
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Billion)
TABLE NO. 6. Global Clinical Trial Imaging Market for Project and Data Management, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 7. Global Clinical Trial Imaging Market for Clinical Trial Design and Consultation, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 8. Global Clinical Trial Imaging Market for Reading and Analytical, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 9. Global Clinical Trial Imaging Market for Operational Imaging, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 10. Global Clinical Trial Imaging Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 11. Global Clinical Trial Imaging Market for CT, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 12. Global Clinical Trial Imaging Market for MRI, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 13. Global Clinical Trial Imaging Market for PET, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 14. Global Clinical Trial Imaging Market for Ultrasound, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 15. Global Clinical Trial Imaging Market for X-Ray, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 16. Global Clinical Trial Imaging Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 17. Global Clinical Trial Imaging Market for Biotechnology and Pharmaceutical Companies, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 18. Global Clinical Trial Imaging Market for Medical Devices Manufacturers, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 19. Global Clinical Trial Imaging Market for Contract Research Organizations (CROs), by Region, 2016 – 2028 (USD Billion)
TABLE NO. 20. Global Clinical Trial Imaging Market for Academic and Government Research Institutes, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 21. Global Clinical Trial Imaging Market for Others, by Region, 2016 – 2028 (USD Billion)
TABLE NO. 22. Global Clinical Trial Imaging Market Revenue, By Region, 2016 – 2028 (USD Billion)
TABLE NO. 23. North America Clinical Trial Imaging Market Revenue, By Country, 2016 – 2028 (USD Billion)
TABLE NO. 24. North America Clinical Trial Imaging Market Revenue, By Services, 2016 – 2028 (USD Billion)
TABLE NO. 25. North America Clinical Trial Imaging Market Revenue, By Modality, 2016 – 2028 (USD Billion)
TABLE NO. 26. North America Clinical Trial Imaging Market Revenue, By End Use, 2016 – 2028 (USD Billion)
TABLE NO. 27. U.S. Clinical Trial Imaging Market Revenue, By Services, 2016 – 2028 (USD Billion)
TABLE NO. 28. U.S. Clinical Trial Imaging Market Revenue, By Modality, 2016 – 2028 (USD Billion)
TABLE NO. 29. U.S. Clinical Trial Imaging Market Revenue, By End Use, 2016 – 2028 (USD Billion)
TABLE NO. 30. Canada Clinical Trial Imaging Market Revenue, By Services, 2016 – 2028 (USD Billion)
TABLE NO. 31. Canada Clinical Trial Imaging Market Revenue, By Modality, 2016 – 2028 (USD Billion)
TABLE NO. 32. Canada Clinical Trial Imaging Market Revenue, By End Use, 2016 – 2028 (USD Billion)
TABLE NO. 33. Mexico Clinical Trial Imaging Market Revenue, By Services, 2016 – 2028 (USD Billion)
TABLE NO. 34. Mexico Clinical Trial Imaging Market Revenue, By Modality, 2016 – 2028 (USD Billion)
TABLE NO. 35. Mexico Clinical Trial Imaging Market Revenue, By End Use, 2016 – 2028 (USD Billion)
TABLE NO. 36. Drivers for the Clinical Trial Imaging Market: Impact Analysis
TABLE NO. 37. Restraints for the Clinical Trial Imaging Market: Impact Analysis
TABLE NO. 38. Major Buyers of Clinical Trial Imaging
TABLE NO. 39. Distributors/Traders List of Clinical Trial Imaging
TABLE NO. 40. Global Clinical Trial Imaging Market, Company Market Revenue, 2016 – 2019 (USD Billion)
TABLE NO. 41. Global Clinical Trial Imaging Market, Company Y-o-Y Growth, 2017 – 2019 (USD Billion)
 

Methodology

Choose License Type

Request the coronavirus impact analysis across industries and markets

FrequentlyAsked Questions

The global clinical trial imaging market was valued at USD 963.36 Billion in 2020.

 

The global clinical trial imaging market is expected to reach USD 1568.83 Billion by 2028, growing at a CAGR of 6.54% between 2021 to 2028.

Some of the key factors driving the global clinical trial imaging market growth are increase in the number of contract research organizations, in the geriatric population with chronic diseases, and a rise in R&D expenditure, the emerging of pharmaceutical and biotechnology sectors, as well as of small and portable equipments market.

Asia Pacific region held a substantial share of the clinical trial imaging market in 2020. This can be attributed to the region's rapid population expansion and increased research and development activities. In addition, traditional and advanced devices and therapies are in great demand across the Asia Pacific region.

Some of the major companies operating in the clinical trial imaging market are Bioclinica Inc, Ixico PLC, Icon PLC, Intrinsic Imaging LLC, Radiant Sage LLC, Parexel International Corporation, Biomedical Systems Worldcare Clinical, Medpace, Navitas Life Sciences, Prism Clinical Imaging, Resonance Health, VirtualScopic Inc and BioTelemetric, Inc. among others.
 

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (844) 845-5245
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No 020-46277770

Contact #

US OFFICE NO +1 (844) 845-5245
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed